Research Portal

Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression

Research output: Contribution to journal › Article › peer-review

Standard Standard

Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. / Le Noury, Joanna; Nardo, John M.; Healy, David et al.
In: International Journal of Risk & Safety in Medicine, Vol. 28, No. 3, 17.09.2016, p. 143-161.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Le Noury, J, Nardo, JM, Healy, D, Jureidini, J, Raven, M, Tufanaru, C & Abi-Jaoude, E 2016, 'Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression', International Journal of Risk & Safety in Medicine, vol. 28, no. 3, pp. 143-161. https://doi.org/10.3233/JRS-160728

APA

Le Noury, J., Nardo, J. M., Healy, D., Jureidini, J., Raven, M., Tufanaru, C., & Abi-Jaoude, E. (2016). Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. International Journal of Risk & Safety in Medicine, 28(3), 143-161. https://doi.org/10.3233/JRS-160728

CBE

Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E. 2016. Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. International Journal of Risk & Safety in Medicine. 28(3):143-161. https://doi.org/10.3233/JRS-160728

MLA

Le Noury, Joanna et al. "Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression". International Journal of Risk & Safety in Medicine. 2016, 28(3). 143-161. https://doi.org/10.3233/JRS-160728

VancouverVancouver

Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C et al. Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. International Journal of Risk & Safety in Medicine. 2016 Sept 17;28(3):143-161. doi: 10.3233/JRS-160728

Author

Le Noury, Joanna ; Nardo, John M. ; Healy, David et al. / Study 329 continuation phase : Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. In: International Journal of Risk & Safety in Medicine. 2016 ; Vol. 28, No. 3. pp. 143-161.

RIS

TY - JOUR

T1 - Study 329 continuation phase

T2 - Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression

AU - Le Noury, Joanna

AU - Nardo, John M.

AU - Healy, David

AU - Jureidini, Jon

AU - Raven, Melissa

AU - Tufanaru, Catalin

AU - Abi-Jaoude, Elia

PY - 2016/9/17

Y1 - 2016/9/17

U2 - 10.3233/JRS-160728

DO - 10.3233/JRS-160728

M3 - Article

VL - 28

SP - 143

EP - 161

JO - International Journal of Risk & Safety in Medicine

JF - International Journal of Risk & Safety in Medicine

SN - 0924-6479

IS - 3

ER -